FLT3 and acute myeloid leukemia: FLT3 genetic testing, detecting both ITD and TKD mutations, is recommended by the National Comprehensive Cancer Network (10) and European Leukemia Net (3) for diagnostic workup of patients with AML, to identify those who may benefit from different targeted treatment options.